POST-MARKETING SAFETY STUDIES Authors' reply to Fralick and Kesselheim

被引：0
|
作者：
Spelsberg, Angela [1 ,2 ]
Keil, Ulrich [3 ]
Prugger, Christof [4 ]
机构：
[1] Transparency Int Germany, Working Grp Hlth, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Comprehens Canc Ctr Aachen, Pauwelsstr 30, D-52074 Aachen, Germany
[3] Univ Munster, Inst Epidemiol & Social Med, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[4] Charite, Inst Publ Hlth, Seestr 73, D-13347 Berlin, Germany
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2017年 / 357卷
关键词：
D O I：
10.1136/bmj.j1850
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Post-marketing studies: the Italian CRONOS project
    Raschetti, R
    Maggini, M
    Vanacore, N
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) : 962 - 962
  • [22] POST-MARKETING STUDIES OF DRUG EFFICACY - HOW
    STROM, BL
    MIETTINEN, OS
    MELMON, KL
    AMERICAN JOURNAL OF MEDICINE, 1984, 77 (04): : 703 - 708
  • [23] REPORT ON A CONFERENCE - POST-MARKETING DRUG SAFETY MONITORING
    CLARKNIEUWLAND, K
    DEHAEN, F
    TEIRLYNCK, O
    HEALTH POLICY, 1989, 11 (03) : 239 - 241
  • [24] Eslicarbazepine acetate: update of post-marketing safety data
    Vieira, M.
    Gama, H.
    Graca, J.
    Costa, R.
    Sousa, R.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 773 - 773
  • [25] Post-marketing Safety profile of ferric carboxymaltose (FERINJECT®)
    Chenaf, C.
    Pagani, M.
    Parry, E.
    Jonville-Bera, A. P.
    Lagarce, L.
    Jean-Pastor, M. J.
    Tonnay, V.
    Eschalier, A.
    Zenut, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 101 - 101
  • [26] Post-marketing safety surveillance of the rotavirus vaccine in India
    Kang, Gagandeep
    Lakhkar, Anand
    Bhamare, Chetanraj
    Dharmadhikari, Abhijeet
    Narwadkar, Jyoti
    Kanujia, Arti
    Desai, Sajjad
    Gunale, Bhagwat
    Poonawalla, Cyrus S.
    Kulkarni, Prasad S.
    VACCINE: X, 2023, 15
  • [27] Utilization of Genomic Biomarkers for Post-marketing Safety of Drugs
    Kaniwa, Nahoko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (05): : 671 - 679
  • [28] Post-marketing drug safety in the era of genomic medicine
    Zavras, AI
    JOURNAL OF DENTAL RESEARCH, 2005, 84 (02) : 105 - 106
  • [29] Post-Marketing Safety Surveillance: Incorporation of a Test for Trends
    Kellier-Steele, Nicole
    Thompson, E. Alan
    Crowe, Brenda
    Hornbuckle, Kenneth
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 109 - 110
  • [30] Fluvoxamine: Safety profile in extensive post-marketing surveillance
    Buchberger, R
    Wagner, W
    PHARMACOPSYCHIATRY, 2002, 35 (03) : 101 - 108
12345